Related references
Note: Only part of the references are listed.Let's go beyond the effect of: Reappraising the impact of ordinary activities on cognition
Rafael Roman-Caballero et al.
PSICOLOGICA (2023)
Effect of Aspirin on Vascular and Nonvascular Outcomes Meta-analysis of Randomized Controlled Trials
Sreenivasa Rao Kondapally Seshasai et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Aspirin use and breast cancer risk: a meta-analysis
Ting Luo et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Aspirin use and risk for lung cancer: a meta-analysis
S. -W. Oh et al.
ANNALS OF ONCOLOGY (2011)
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study
Aditya Bardia et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
R. E. Langley et al.
BRITISH JOURNAL OF CANCER (2011)
Regular aspirin use and breast cancer risk in US Black Women
Jaclyn L. F. Bosco et al.
CANCER CAUSES & CONTROL (2011)
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype
Theodore M. Brasky et al.
CANCER CAUSES & CONTROL (2011)
Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006
Preet K. Dhillon et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study
Salaheddin M. Mahmud et al.
PLOS ONE (2011)
Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer Risk
Claudia A. Salinas et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study
Theodore M. Brasky et al.
CANCER CAUSES & CONTROL (2010)
Nonsteroidal Anti-Inflammatory Drugs and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort
Theodore M. Brasky et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis
Ping Yang et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Aspirin and gastric cancer risk
Paola Bertuccio et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Farhat V. N. Din et al.
GUT (2010)
Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis
Salaheddin M. Mahmud et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A Case-Control Study of Levothyroxine and the Risk of Colorectal Cancer
Gad Rennert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
A Prospective Study of Aspirin Use and the Risk of Gastrointestinal Bleeding in Men
Edward S. Huang et al.
PLOS ONE (2010)
Nonsteroidal Antiinflammatory Drugs and Risk of Gastric Adenocarcinoma
Meira Epplein et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Use of Aspirin, Other Nonsteroidal Anti-inflammatory Drugs, and Acetaminophen and Risk of Breast Cancer Among Premenopausal Women in the Nurses' Health Study II
A. Heather Eliassen et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
Ya-shuang Zhao et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
C. C. Abnet et al.
BRITISH JOURNAL OF CANCER (2009)
Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study
Soren Friis et al.
CANCER CAUSES & CONTROL (2009)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Aspirin, salicylates, and cancer
Peter C. Elwood et al.
LANCET (2009)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Use of Nonsteroidal Antiinflammatory Drugs and Distal Large Bowel Cancer in Whites and African Americans
Sangmi Kim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
Randall E. Harris et al.
BMC CANCER (2008)
Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County
Lei Duan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Protective Effect of NSAIDs on Cancer and Influence of COX-2 C-765G Genotype
C. Siemes et al.
CURRENT CANCER DRUG TARGETS (2008)
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study
Soren Friis et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
Aspirin and folic acid for the prevention of recurrent colorectal adenomas
Richard F. A. Logan et al.
GASTROENTEROLOGY (2008)
Aspirin dose and duration of use and risk of colorectal cancer in men
Andrew T. Chan et al.
GASTROENTEROLOGY (2008)
Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis
Bahi Takkouche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
NSAID use and breast cancer risk in the VITAL cohort
Ann Ready et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005
Sandra Mangiapane et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study
Gretchen L. Gierach et al.
BREAST CANCER RESEARCH (2008)
Nonsteroidal antiinflammatory drugs and breast cancer risk - The multiethnic cohort
Jasmeet K. Gill et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Meta-analysis:: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories
G. Capurso et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Nonsteroidal antlinflammatory drug use and breast cancer risk: Subgroup findings
Victoria A. Kirsh et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: Nested case-control study
Yana Vinogradova et al.
GASTROENTEROLOGY (2007)
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence
Eric J. Jacobs et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Long-term aspirin use and mortality in women
Andrew T. Chan et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: A meta-analysis
Susanna C. Larsson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden
S. C. Larsson et al.
BRITISH JOURNAL OF CANCER (2006)
Epidemiologic aspects of renal cell carcinoma
Joseph K. McLaughlin et al.
SEMINARS IN ONCOLOGY (2006)
Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa Women's Health Study
Amit Mahipal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
The association between aspirin use and the incidence of colorectal cancer in women
Matthew Allison et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain
Joan Fortuny et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials
Kenneth R. McQuaid et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Regular use of aspirin and prostate cancer risk (United States)
RJ Menezes et al.
CANCER CAUSES & CONTROL (2006)
Aspirin and the risk of prostate cancer
C Bosetti et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2006)
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
RE Harris et al.
BMC CANCER (2006)
Aspirin and cancer risk: an updated quantitative review to 2005
Cristina Bosetti et al.
CANCER CAUSES & CONTROL (2006)
Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites
LB Sansbury et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer
AT Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: The case-control surveillance study revisited
YQ Zhang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial
NR Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence
EJ Jacobs et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status
SF Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging
EA Platz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Association of regular aspirin use and breast cancer risk
H Swede et al.
ONCOLOGY (2005)
Risk of breast cancer among users of aspirin and other antiinflammatory drugs
LAG Rodríguez et al.
BRITISH JOURNAL OF CANCER (2004)
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk
MB Terry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer
L Perron et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial
R Benamouzig et al.
GASTROENTEROLOGY (2003)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
RS Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Aspirin and cancer risk: an update to 2001
C Bosetti et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US
LA Habel et al.
CANCER CAUSES & CONTROL (2002)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents
S Fiorucci et al.
DIGESTIVE AND LIVER DISEASE (2001)
Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs
LAG Rodriguez et al.
EPIDEMIOLOGY (2001)
Publication bias in meta-analysis: its causes and consequences
A Thornton et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)